Form 4: Broadway Financial Corp Director Marie C Johns Acquires Shares
SEC Form 4 Filing
Director Marie C Johns acquired 2,479 shares of Broadway Financial Corp common stock at $4.84 per share on May 22, 2024.
Summary
- On May 22, 2024, Marie C Johns, a director of Broadway Financial Corp, acquired 2,479 shares of common stock.
- The shares were acquired at a price of $4.84 per share.
- This acquisition was part of an award of unrestricted stock issued pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.
- Following the transaction, Johns directly owns 4,644 shares of Broadway Financial Corp common stock, adjusted for a reverse stock split effective October 31, 2023.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director acquiring shares can be seen as a positive sign, but the transaction is relatively small and part of a pre-existing incentive plan.
Positives
- The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's performance and future prospects. This transaction is a routine disclosure of a director's stock acquisition.
Stakeholder Impact
- The acquisition of shares by a director may have a minor positive impact on shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| October 31, 2023 | Effective date of reverse stock split. |
| May 22, 2024 | Date of the share acquisition by Marie C Johns. |
| May 23, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.